- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/015 - Antigènes d'Hemosporidia, p. ex. antigènes de Plasmodium
Détention brevets de la classe A61K 39/015
Brevets de cette classe: 682
Historique des publications depuis 10 ans
|
50
|
51
|
35
|
46
|
41
|
28
|
29
|
46
|
27
|
32
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Oxford University Innovation Limited | 1675 |
26 |
| Glaxosmithkline Biologicals S.A. | 1602 |
21 |
| Sanaria Inc. | 39 |
21 |
| BioNTech SE | 825 |
20 |
| Institut Pasteur | 776 |
19 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
19 |
| Isis Innovation Limited | 445 |
10 |
| Leidos, Inc. | 204 |
10 |
| Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 156 |
10 |
| The Trustees of the University of Pennsylvania | 4432 |
9 |
| University of Washington | 2458 |
9 |
| The United States of America as represented by the Secretary of the Navy | 2865 |
8 |
| The Hospital for Sick Children | 414 |
8 |
| Rhode Island Hospital | 201 |
8 |
| The Wistar Institute of Anatomy and Biology | 487 |
8 |
| Centre National de La Recherche Scientifique | 11077 |
7 |
| Board of Trustees of the University of Arkansas | 834 |
7 |
| GenVec, Inc. | 52 |
7 |
| Griffith University | 161 |
7 |
| Modernatx, Inc. | 1282 |
7 |
| Autres propriétaires | 441 |